Chronic Intractable Pruritus in Chronic Kidney Disease Patients: Prevalence, Impact, and Management Challenges - A Narrative Review.
Karolina ŚwierczyńskaRafał Białynicki-BirulaJacek Cezary SzepietowskiPublished in: Therapeutics and clinical risk management (2021)
Chronic kidney disease (CKD) is recognized as a leading public health problem and causes numerous health complications. One of the most common and burdensome dermatological symptoms affecting patients undergoing dialysis is CKD-associated pruritus (CKD-aP). This condition not only has a negative impact on sleep, mood, daily activities, and quality of life but also increases the mortality risk of hemodialyzed patients. Despite that, this condition is greatly underestimated in clinical practice. Due to the complex and still not fully understood etiopathogenesis of CKD-aP, the choice of an effective therapy remains a challenge for clinicians. Most common therapeutic algorithms use topical treatment, phototherapy, and various systemic approaches. This review aimed to summarize most recent theories about the pathogenesis, clinical features, and treatment of CKD-aP.
Keyphrases
- chronic kidney disease
- end stage renal disease
- public health
- peritoneal dialysis
- patients undergoing
- ejection fraction
- transcription factor
- clinical practice
- healthcare
- risk factors
- prognostic factors
- sleep quality
- stem cells
- coronary artery disease
- cardiovascular disease
- palliative care
- cardiovascular events
- combination therapy
- decision making
- global health